Favi, Evaldo
 Distribuzione geografica
Continente #
NA - Nord America 954
AS - Asia 601
EU - Europa 535
SA - Sud America 110
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.232
Nazione #
US - Stati Uniti d'America 936
SG - Singapore 297
DE - Germania 189
CN - Cina 134
SE - Svezia 92
BR - Brasile 87
UA - Ucraina 61
VN - Vietnam 51
FR - Francia 39
IE - Irlanda 35
IT - Italia 34
GB - Regno Unito 29
IN - India 27
FI - Finlandia 20
ID - Indonesia 20
CI - Costa d'Avorio 16
JP - Giappone 15
IQ - Iraq 10
BD - Bangladesh 9
HK - Hong Kong 8
AR - Argentina 7
RU - Federazione Russa 7
ZA - Sudafrica 7
CA - Canada 6
IR - Iran 6
MX - Messico 6
NL - Olanda 6
MA - Marocco 5
PL - Polonia 4
TR - Turchia 4
UZ - Uzbekistan 4
VE - Venezuela 4
BE - Belgio 3
CO - Colombia 3
EC - Ecuador 3
JM - Giamaica 3
AT - Austria 2
BG - Bulgaria 2
CL - Cile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ES - Italia 2
KZ - Kazakistan 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
LC - Santa Lucia 1
LV - Lettonia 1
ME - Montenegro 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PY - Paraguay 1
QA - Qatar 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 2.232
Città #
Chandler 196
Singapore 154
San Jose 86
Ashburn 79
New York 38
Beijing 35
San Mateo 35
Dublin 34
Jacksonville 30
Wilmington 25
Ann Arbor 23
Los Angeles 23
Dearborn 20
Jakarta 19
Ho Chi Minh City 17
Abidjan 16
Hanoi 15
Lauterbourg 15
Boston 14
Tokyo 13
Frankfurt am Main 12
Redwood City 12
Fairfield 11
Nanjing 11
Nürnberg 11
Princeton 11
Houston 9
Hefei 8
Lawrence 8
Milan 8
São Paulo 8
Buffalo 7
Nanchang 7
Augusta 6
Guangzhou 6
Hebei 6
Hong Kong 6
Munich 6
Santa Clara 6
Woodbridge 6
Boardman 5
Dallas 5
London 5
Moscow 5
Portsmouth 5
Redondo Beach 5
Rio de Janeiro 5
Stockholm 5
Zhengzhou 5
Cattolica 4
Chennai 4
Helsinki 4
Marseille 4
Orem 4
Shenyang 4
Tashkent 4
Toronto 4
Warsaw 4
Baghdad 3
Biên Hòa 3
Brooklyn 3
Brussels 3
Costa Mesa 3
Da Nang 3
Johannesburg 3
Leawood 3
Pelotas 3
Recife 3
San Francisco 3
Seattle 3
Turku 3
University Park 3
West Jordan 3
Amsterdam 2
Ankara 2
Bauru 2
Bogotá 2
Bremen 2
Busto Arsizio 2
Cambridge 2
Campo Grande 2
Carapicuíba 2
Franca 2
Fremont 2
Groningen 2
Haiphong 2
Hampton 2
Izmir 2
Kent 2
Kish 2
Kunming 2
Lancaster 2
Las Vegas 2
Lomazzo 2
Manchester 2
Marrakesh 2
Mexico City 2
Mountain View 2
Naples 2
Norwalk 2
Totale 1.232
Nome #
Significant improvement in patient survival after renal transplantation in the last decade. 151
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 150
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 147
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 146
Metabolic Syndrome and Cardiovascular Disease in Kidney Transplantation 136
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 136
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 132
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 123
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 122
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 121
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 111
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 110
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 109
Spontaneous renal allograft rupture complicated by urinary leakage: case report and review of the literature 106
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study 105
Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine 86
Incidence of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients Immunosuppressed With Sirolimus in Combination With Cyclosporine 86
Higher Incidence of Acute Rejection in Renal Transplant Recipients With Low Everolimus Exposure 79
Prospective Clinical Trial Comparing Two Immunosuppressive Regimens, Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine, in De Novo Renal Transplant Recipients: Results at 6 Months Follow-up 70
Predictive Role of the INDANA CV Score System in Kidney Transplant Recipients 17
The Combination of Everolimus and Low Dose Cyclosporine Allows Similar Results as the Standard Tacrolimus and MMF Regimen: 3-Year Results of a Prospective Clinical Trial in Renal Transplant Recipients 7
Suture-free polyglactin 910 mesh repair of kidney graft rupture: A case report and review of literature 6
Totale 2.256
Categoria #
all - tutte 9.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.310


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 30 2
2021/2022148 5 15 1 3 6 2 3 32 10 15 18 38
2022/2023432 49 62 24 91 19 54 24 37 60 4 7 1
2023/2024134 11 45 3 16 3 25 6 1 2 5 8 9
2024/2025299 4 13 22 30 20 2 1 24 51 22 76 34
2025/2026728 119 19 29 77 169 28 129 39 45 71 3 0
Totale 2.256